FRANCES OKPALUBA: Open Payments
NPI 1588180574 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 4 payments from 4 companies in 2025. Trend: 2023 $184 · 2024 $486 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $124 |
| Amgen Inc. | 1 | $124 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| La Jolla Pharmaceutical Company | 1 | $122 |
Products named: ZERBAXA, UPTRAVI, ZEVTERA.
Industry payments across TX — which companies pay providers there.
